✦ LIBER ✦

Redefining the Target Again: Chemotherapeutics as Vascular Disrupting Agents?

✍ Scribed by Yesim Gokmen-Polar; Kathy D. Miller

Book ID: 113523833
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 87 KB
Volume: 14
Category: Article
ISSN: 1535-6108
DOI: 10.1016/j.ccr.2008.08.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erythrocytes as carriers of chemotherape

Erythrocytes as carriers of chemotherapeutic agents for targeting the reticuloendothelial system

✍ William E. Lynch; George P. Sartiano; Abdul Ghaffar 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 651 KB

Design, Synthesis, and Biological Evalua

Design, Synthesis, and Biological Evaluation of the First Podophyllotoxin Analogues as Potential Vascular-Disrupting Agents

✍ Dr. Raphaël Labruère; Dr. Benoît Gautier; Marlène Testud; Johanne Seguin; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 1 views

Ovarian tumor growth regression using a

Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven

✍ Ruud P.M. Dings; Emily S. Van Laar; Jeremy Webber; Yan Zhang; Robert J. Griffin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Inside Cover: Design, Synthesis, and Bio

Inside Cover: Design, Synthesis, and Biological Evaluation of the First Podophyllotoxin Analogues as Potential Vascular-Disrupting Agents (ChemMedChem 12/2010)

✍ Dr. Raphaël Labruère; Dr. Benoît Gautier; Marlène Testud; Johanne Seguin; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

Concise syntheses of N-aryl-5,6,7-trimet

Concise syntheses of N-aryl-5,6,7-trimethoxyindoles as antimitotic and vascular disrupting agents: application of the copper-mediated Ullmann-type arylation

✍ Lee, Hsueh-Yun; Chang, Jang-Yang; Chang, Ling-Yin; Lai, Wen-Yang; Lai, Mei-Jung; 📂 Article 📅 2011 🏛 Royal Society of Chemistry 🌐 English ⚖ 266 KB

A phase II clinical trial of the Vascula

A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma

✍ Nowak, Anna K.; Brown, Chris; Millward, Michael J.; Creaney, Jenette; Byrne, Mic 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 632 KB